← Back to Clinical Trials
Recruiting NCT06272786

NCT06272786 Suprascapular Nerve Block in Patients Rehabilitated After Arthroscopic Rotator Cuff Repair

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06272786
Status Recruiting
Phase
Sponsor Kirsehir Ahi Evran Universitesi
Condition Rotator Cuff Tears
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2024-07-28
Primary Completion 2025-02-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
conventional physiotherapy program.Suprascapular nerve block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2024-07-28 with a primary completion date of 2025-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Suprascapular nerve block is an injection method that has been shown to be effective in shoulder rehabilitation in diseases such as adhesive capsulitis and stroke .. Applying the block under USG guidance instead of blinding increases the effectiveness and reduces complications.

Eligibility Criteria

Inclusion Criteria: -Having undergone arthroscopic rotator cuff repair surgery within the last week Exclusion Criteria: * History of previous surgery on the same shoulder * History of systemic inflammatory rheumatological disease * Neurological diseases with muscle weakness in the upper extremity (MS, ALS, Muscular -Dystrophy) * History of malignancy, pregnancy, breastfeeding * Use of steroids or immunosuppressive drugs * History of allergic reactions to local analgesics * Fibromyalgia syndrome * Chronic painful conditions that require opioid use * Presence of known psychiatric disease * Cognitive impairment (Mini Mental Test Score \<23)

Contact & Investigator

Central Contact

Basak Cigdem Karacay, Asst Prof

✉ basakcigdem@hotmail.com

📞 +9 0386 280 51 00.

Principal Investigator

Basak Cigdem Karacay, Asst Prof

PRINCIPAL INVESTIGATOR

Kirsehir Ahi Evran University

Frequently Asked Questions

Who can join the NCT06272786 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rotator Cuff Tears. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06272786 currently recruiting?

Yes, NCT06272786 is actively recruiting participants. Contact the research team at basakcigdem@hotmail.com for enrollment information.

Where is the NCT06272786 trial being conducted?

This trial is being conducted at Kirşehir, Turkey (Türkiye).

Who is sponsoring the NCT06272786 clinical trial?

NCT06272786 is sponsored by Kirsehir Ahi Evran Universitesi. The principal investigator is Basak Cigdem Karacay, Asst Prof at Kirsehir Ahi Evran University. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology